首页> 外文OA文献 >PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK BUDGET IMPACT ANALYSIS

【2h】

PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK BUDGET IMPACT ANALYSIS

机译：PCN4静脉内（IV）佐敦酸的经济评估VS.其他IV双歧杆菌在预防患有骨转移的乳腺癌患者中的骨并发症：英国预算影响分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Botteman M; Aapro M; Hay JW; Stephens J; Brandman J;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. [J] . De Cock E, Hutton J, Canney P, Clinical therapeutics . 2005,第8期

机译：在英国，口服伊班膦酸与IV唑来膦酸或IV帕米膦酸在接受口服激素治疗乳腺癌的患者中的骨转移的成本效益。
2. 418 POSTER Cost-effectiveness of zoledronic acid vs. other bisphosphonate agents for the prevention of bone complications in breast cancer: an application to Canada [J] . European Journal of Cancer Supplements . 2005,第2期

机译：418 POSTER唑来膦酸与其他双膦酸酯类药物在预防乳腺癌骨并发症方面的成本效益：在加拿大的应用
3. 423 POSTER A markov model to evaluate the cost effectiveness of five bisphosphonate therapies in the prevention of bone complications in breast cancer patients with bone metastases: a German outpatient perspective [J] . European Journal of Cancer Supplements . 2005,第2期

机译：423 POSTER Markov模型用于评估五种双膦酸盐疗法在预防骨转移乳腺癌患者骨并发症中的成本效益：德国门诊患者的观点
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Analysis of bone activity of jaws using scintigraphy on patients before, during and after treatment with IV bisphosphonates: A retrospective study. [D] . Handoo, Nidhi Q. 2009

机译：使用闪烁闪烁照相术分析静脉注射双膦酸盐治疗前后患者颌骨的骨活动：一项回顾性研究。
6. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised crossover study of community vs hospital bisphosphonate administration [O] . A Wardley, N Davidson, P Barrett-Lee, 2005

机译：唑来膦酸显着改善患有骨转移的乳腺癌患者的疼痛评分和生活质量：社区与医院双磷酸盐治疗的随机交叉研究
7. PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK NHS PERSPECTIVE [O] . Botteman M, Aapro M, Stephens J, 2005

机译：静脉（IV）佐力膦酸VS的PCN5预算影响分析。口服IBANDRONATE或IV通用PAMIDRONATE在预防患有骨转移的乳腺癌患者的骨并发症中的作用：英国NHS的观点

PCN4 ECONOMIC EVALUATION OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. OTHER IV BISPHOSPHONATES IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES: A UK BUDGET IMPACT ANALYSIS

著录项

相似文献

相关主题

期刊订阅